LATIN AMERICA BIOSURGERY MARKET 2019-2027

MARKET OUTLOOK
Triton, in its research report, estimates the Latin America biosurgery market to proliferate with a compound annual growth rate of 9.62% in the forecast years of 2019-2027.
Brazil, Mexico and countries in rest of Latin America have been studied for the report on the Latin American biosurgery market.
The growing demand for MIS, biologics and instrumentation has led to more reliable spinal fusion and has reduced patient morbidity. Degeneration of bones and joints, brought about by aging leads to instability and stenosis. This has increased the demand for spinal fusion and joint reconstruction. Spinal fusion and repair help in disc herniation, traumatic spinal injuries, congenital & degenerative spinal conditions and tumor removal. Thus, the rise in spinal fusion and joint reconstruction has positively influenced the biosurgery market.
Though orthopedics surgeries have many advantages such as facilitating quick healing, aiding better repair & recovery of bone, less painful experience as compared to other procedures etc., the high cost of surgery involved is a major restraining factor for the growth of this market. The cost of extensive novel bone grafts makes it difficult to obtain reimbursement for surgeries, and this results in the low adoption of orthobiologics in nations having low economic conditions. Thus, the high cost of surgeries is expected to hamper the market growth. Thus, despite being constructive, it restrains the market growth.
COMPETITIVE OUTLOOK
Stryker Corporation, Ethicon, Inc., Sanofi, Medtronic Plc, Baxter International, Inc., Smith & Nephew Plc, Ypsomed Holding AG, Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., RTI Surgical, Olympus Corporation, B. Braun Melsungen AG and Johnson & Johnson are some of the contending players in the biosurgery market.

TABLE OF CONTENTS
1. BIOSURGERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. TRENDS IN BIOSURGERY TECHNOLOGY
2.3. REGULATORY FRAMEWORK
2.4. KEY VENDORS OUTLOOK
2.5. KEY INSIGHTS
2.6. KEY BUYING OUTLOOK
2.7. KEY PATENT OUTLOOK
2.8. MARKET DRIVERS
2.8.1. RISE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.8.2. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
2.8.3. INCREASING TRAUMA-RELATED WOUNDS
2.9. MARKET RESTRAINTS
2.9.1. STRINGENT REGULATORY APPROVAL
2.9.2. INCREASE IN THE COST OF SURGERIES
2.9.3. INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES
2.9.4. LACK OF AWARENESS
2.10. MARKET OPPORTUNITIES
2.10.1. DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
2.10.2. INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING
2.11. MARKET CHALLENGES
2.11.1. AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
2.11.2. COMPLICATION RELATED TO IMMUNE RESPONSE
2.11.3. LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS
2.11.4. PRODUCT SIDE-EFFECTS AND FDA INQUIRY
3. BIOSURGERY MARKET OUTLOOK - BY PRODUCTS
3.1. BONE-GRAFT SUBSTITUTES
3.1.1. SYNTHETIC GRAFT EXTENDER
3.1.2. DEMINERALIZED BONE MATRIX
3.1.3. BONE MORPHOGENETIC PROTEINS
3.1.4. CELL-BASED MATRICES
3.2. HEMOSTATIC AGENTS
3.3. SOFT-TISSUE MANAGEMENT
3.3.1. SYNTHETIC MESH/PATCH
3.3.2. NATURAL MESH/PATCH
3.4. SURGICAL SEALING AGENTS
3.4.1. NATURAL SURGICAL SEALING AGENTS
3.4.2. SYNTHETIC SURGICAL SEALING AGENTS
3.5. ANTI-ADHESIVE AGENTS
4. BIOSURGERY MARKET OUTLOOK - BY APPLICATION
4.1. NEURO AND SPINE SURGERY
4.2. CARDIO AND THORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDIC SURGERY
5. BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. LATIN AMERICA
6.1.1. COUNTRY ANALYSIS
6.1.1.1. BRAZIL
6.1.1.2. MEXICO
6.1.1.3. REST OF LATIN AMERICA
7. COMPETITIVE LANDSCAPE
7.1. B. BRAUN MELSUNGEN AG
7.2. JOHNSON & JOHNSON
7.3. BAXTER INTERNATIONAL, INC.
7.4. ETHICON, INC.
7.5. MEDTRONIC PLC
7.6. SANOFI
7.7. OLYMPUS CORPORATION
7.8. RTI SURGICAL
7.9. SMITH & NEPHEW PLC
7.10. STRYKER CORPORATION
7.11. ZIMMER BIOMET HOLDINGS, INC.
7.12. WRIGHT MEDICAL GROUP N.V.
7.13. YPSOMED HOLDING AG
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY




TABLE LIST
TABLE 1 LATIN AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
TABLE 2 MEDICAL DEVICE CLASSIFICATION
TABLE 3 TYPES OF PMA SUPPLEMENTS
TABLE 4 MEDICAL DEVICES BY CLASS
TABLE 5 LATIN AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 6 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 7 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 8 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 9 LATIN AMERICA BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)
TABLE 10 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 11 LATIN AMERICA BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2019-2027 (IN $ MILLION)
TABLE 12 LATIN AMERICA BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)
TABLE 13 TYPES OF CARDIOVASCULAR DISEASES
TABLE 14 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 15 LATIN AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 16 LATIN AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)




FIGURES LIST
FIGURE 1 LATIN AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 2 KEY STRATEGIES IN BIOSURGERY MARKET
FIGURE 3 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 4 LATIN AMERICA BIOSURGERY MARKET BY BONE-GRAFT SUBSTITUTES 2019-2027 (IN $ MILLION)
FIGURE 5 LATIN AMERICA BONE-GRAFT SUBSTITUTES MARKET BY SYNTHETIC GRAFT EXTENDERS 2019-2027 (IN $ MILLION)
FIGURE 6 LATIN AMERICA BONE-GRAFT SUBSTITUTES MARKET BY DEMINERALIZED BONE MATRIX 2019-2027 (IN $ MILLION)
FIGURE 7 LATIN AMERICA BONE-GRAFT SUBSTITUTES MARKET BY BONE MORPHOGENETIC PROTEINS 2019-2027 (IN $ MILLION)
FIGURE 8 LATIN AMERICA BONE-GRAFT SUBSTITUTES MARKET BY CELL-BASED MATRICES 2019-2027 (IN $ MILLION)
FIGURE 9 LATIN AMERICA BIOSURGERY MARKET BY HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)
FIGURE 10 LATIN AMERICA BIOSURGERY MARKET BY SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 11 LATIN AMERICA BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 12 LATIN AMERICA SOFT-TISSUE MANAGEMENT MARKET BY SYNTHETIC MESHES 2019-2027 (IN $ MILLION)
FIGURE 13 LATIN AMERICA BIOSURGERY MARKET BY SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)
FIGURE 14 LATIN AMERICA SURGICAL SEALING AGENTS MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 15 LATIN AMERICA SURGICAL SEALING AGENTS MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 16 LATIN AMERICA BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)
FIGURE 17 LATIN AMERICA BIOSURGERY MARKET BY NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)
FIGURE 18 LATIN AMERICA BIOSURGERY MARKET BY CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 19 LATIN AMERICA BIOSURGERY MARKET BY GENERAL SURGERY 2019-2027 (IN $ MILLION)
FIGURE 20 LATIN AMERICA BIOSURGERY MARKET BY ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 21 LATIN AMERICA BIOSURGERY MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 22 LATIN AMERICA BIOSURGERY MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 23 BRAZIL BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 24 MEXICO BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 25 REST OF LATIN AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)